# Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

> **NCT00098566** · — · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 36 (actual)

## Conditions studied

- Lymphoma
- Quality of Life

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00098566
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00098566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00098566, "Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00098566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*